Clin2
NCT07533292Possibly a fitNot yet recruiting

Bacteriophage Therapy for Implant Infections

OrthopedicImplant Infection

Treatments studied

Part of Infections clinical trials.

This trial tests whether specially designed viruses (bacteriophages) can treat infections around orthopedic implants like joint replacements or bone hardware. Bacteriophages are natural virus-like particles that attack bacteria, and this study evaluates whether they are safe and effective when given to patients with hard-to-treat implant infections.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You do not have a known allergy or sensitivity to bacteriophages or the preparation used in the trial
  • You are not pregnant or currently breastfeeding
  • You are not enrolled in another medical trial at the same time
  • You can receive treatment through an intravenous (IV) line, or another feasible way to receive the therapy
  • You are willing and able to follow all study procedures and appointments
  • Your doctor believes you are healthy enough to participate safely

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07461337Not yet recruiting· Phase 1/Phase 2
Phage therapy for a resistant joint infection

This trial tests a virus-based treatment (bacteriophage) for a chronic joint infection caused by a specific bacteria that hasn't responded to other treatments.

Calgary
NCT06942624Not yet recruiting· Phase 1/Phase 2
Phage therapy for a persistent joint infection

This trial tests a virus-based treatment for a chronic hip or knee implant infection caused by a hard-to-treat bacteria. It is designed as a single-patient study that may help when standard treatments have failed.

Winnipeg, Manitoba
NCT06605651Not yet recruiting· Phase 2
Phage therapy for staph infections in hip or knee replacements

This study tests a treatment using viruses (phages) that kill staph bacteria in people with an infected hip or knee replacement. The treatment is given after a surgery to clean the joint, and the goal is to see if it's safe and effective.

NCT07698002Not yet recruiting· Phase 2/Phase 3
Phage therapy for joint infections

This trial studies a new treatment using viruses (phages) that target specific bacteria. If you have a hip or knee joint infection caused by a single type of bacteria (Staph aureus or Pseudomonas) and are having a surgery to clean the joint, this trial may be an option for you.

Ottawa
NCT04650607Recruiting
Phage therapy safety check in serious infection patients

This study checks the safety of using phage therapy (viruses that target certain bacteria) in adults being treated for serious infections. If you meet the safety rules, your care team may enroll you to help confirm phage treatment is safe.

Lyon
NCT07619924Enrolling by invitation· Early Phase 1
Phage Cocktail for Hard-to-Treat Skin Infections

This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.

Xi'an, Shaanxi

Hear when a new Implant Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.